Inhibitory MHC class I receptors on NK cells and T cells
- PMID: 8808056
- DOI: 10.1016/0167-5699(96)80585-8
Inhibitory MHC class I receptors on NK cells and T cells
Abstract
Natural killer (NK) and T cells express receptors for polymorphic major histocompatibility complex (MHC) class I molecules, and activation of these receptors results in inhibition of their effector cell function. Genes encoding the murine and human NK-cell receptors have been cloned, and studies of their structure, function and expression are progressing rapidly, as reviewed here by Lewis Lanier and Joseph Phillips.
Comment in
-
Ontogeny of inhibitory receptors for MHC molecules on NK cells.Immunol Today. 1997 Mar;18(3):146. doi: 10.1016/s0167-5699(97)85959-2. Immunol Today. 1997. PMID: 9078688 No abstract available.
Similar articles
-
Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature.Immunol Today. 1996 Feb;17(2):100. doi: 10.1016/0167-5699(96)80590-1. Immunol Today. 1996. PMID: 8808061 No abstract available.
-
Expression of inhibitory receptors for MHC class I molecules on T cells.Crit Rev Immunol. 2000;20(6):471-6. Crit Rev Immunol. 2000. PMID: 11396682 Review.
-
Human NK cell education by inhibitory receptors for MHC class I.Immunity. 2006 Aug;25(2):331-42. doi: 10.1016/j.immuni.2006.06.013. Epub 2006 Aug 10. Immunity. 2006. PMID: 16901727
-
Regulation of the natural killer cell receptor repertoire.Annu Rev Immunol. 2001;19:291-330. doi: 10.1146/annurev.immunol.19.1.291. Annu Rev Immunol. 2001. PMID: 11244039 Review.
-
MHC class I receptors on natural killer cells: on with the old and in with the new.Clin Sci (Lond). 2003 Aug;105(2):127-40. doi: 10.1042/CS20030095. Clin Sci (Lond). 2003. PMID: 12737620 Review.
Cited by
-
Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas.Br J Cancer. 1999 Nov;81(5):881-9. doi: 10.1038/sj.bjc.6690780. Br J Cancer. 1999. PMID: 10555762 Free PMC article.
-
Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.Mediators Inflamm. 1999;8(6):313-8. doi: 10.1080/09629359990324. Mediators Inflamm. 1999. PMID: 10815620 Free PMC article.
-
Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.Br J Cancer. 1998 Apr;77(7):1072-81. doi: 10.1038/bjc.1998.179. Br J Cancer. 1998. PMID: 9569042 Free PMC article.
-
Expression of CISH, an Inhibitor of NK Cell Function, Increases in Association with Ovarian Cancer Development and Progression.Biomedicines. 2023 Jan 21;11(2):299. doi: 10.3390/biomedicines11020299. Biomedicines. 2023. PMID: 36830840 Free PMC article.
-
Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.J Exp Med. 1997 Jul 7;186(1):109-20. doi: 10.1084/jem.186.1.109. J Exp Med. 1997. PMID: 9207002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials